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Ineffectiveness of Livings Wills Focus of 
Lawrence University Biomedical Ethics 
Lecture 
Posted on: January 3rd, 2005 by Rick Peterson 
A University of Michigan medical school and Ann Arbor VA 
research investigator argues that a staple of the American medical 
culture – the living will – does not nor cannot work in the second 
installment of Lawrence University’s four-part 2004-05 Edward F. 
Mielke Lecture Series in Biomedical Ethics. 
Angela Fagerlin presents “Pulling the Plug on Living Wills: How 
Living Wills have Failed to Live up to Their Mandate,” 
Wednesday, Jan. 12 at 7 p.m. in Lawrence’s Wriston Art Center 
auditorium. The address, which will examine the shortcomings of 
living wills as well as the use of durable power of attorney as an 
alternative to living wills, is free and open to the public. 
Living wills were originally created as a means of enabling an 
individual to maintain a certain level of control at the end of their 
life by detailing the types of treatment a person would like to 
receive or measures they would like taken should they become 
incapacitated and unable to make their own decisions. It is a 
document widely recommended by experts, recognized by law in 
nearly every state and one that hospitals are federally mandated to 
inform their patients about. 
But in a recently published research paper, Fagerlin and her 
colleague Carl Schneider claim living wills consistently fail the 
basic criteria necessary for them to be effective, thus giving them 
little relevance in actual end-of-life decisions. According to 
Fagerlin, among the problems with living wills is the inability of 
most individuals to state their wishes accurately and 
understandably and having the document available when treatment 
decisions need to be made. The effectiveness of living wills, she 
argues, is further compromised by advances in medical technology 
and changes in an individual’s personal situation. The paper she 
co-authored was based on a review of hundreds of living wills and 
end-of-life decisions. 
An internal medicine researcher in the University of Michigan 
medical school’s Program for Improving Health Care Decisions 
and the Ann Arbor Veteran’s Affairs Medical Center, Fagerlin 
earned her Ph.D. in experimental psychology from Kent State 
University. In addition to advanced directives and end-of-life 
decisions, she has written articles on topics ranging from racial 
differences in the treatment of prostate cancer to the use of 
decision aids to facilitate patient involvement in their medical care.	  
